New York Clears Interleukin Genetics' Dental Test | GenomeWeb

NEW YORK (GenomeWeb News) – Interleukin Genetics has received clearance in the State of New York to offer its genetic test for risk of periodontal disease, the company said today.

The State of New York's Department of Health approved the firm's PST Genetic Test through its Clinical Laboratory Evaluation Program, which monitors the accuracy and reliability of the results of lab tests and specimens obtained within the state.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.